CLRB
Price:
$2.23
Market Cap:
$7.12M
Cellectar Biosciences is a biopharmaceutical firm engaged in the research, development, and market introduction of therapeutic agents to combat cancer. The company's primary asset is CLR 131 (iopofosine I-131), a phospholipid drug conjugate (PDC), which is currently undergoing several clinical evaluations. It is in Phase 2 clinical trials for individuals with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia and B-cell malignancies. Additionally, CLR 131 is being studied in Phase 2B for r/r multiple myeloma (MM) and in Phase I trials targeting a range of pediatric cancers, r/r head and neck cancers, and R/R MM. Furthermore, Cellectar is advancing CLR 1900, another PDC-based chemot...[Read more]
Industry
Biotechnology
IPO Date
2005-11-10
Stock Exchange
NASDAQ
Ticker
CLRB
According to Cellectar Biosciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 299.98K. This represents a change of -88.13% compared to the average of 2.53M of the last 4 quarters.
The mean historical Enterprise Value of Cellectar Biosciences, Inc. over the last ten years is -1187213.84. The current 299.98K Enterprise Value has changed -2626.79% with respect to the historical average. Over the past ten years (40 quarters), CLRB's Enterprise Value was at its highest in in the March 2017 quarter at 806.66M. The Enterprise Value was at its lowest in in the June 2024 quarter at -12409551.00.
Average
-1187213.84
Median
-5558331.92
Minimum
-15533525.00
Maximum
24.84M
Discovering the peaks and valleys of Cellectar Biosciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Enterprise Value = 24.84M
Minimum Annual Increase = -681.34%
Minimum Annual Enterprise Value = -15533525.00
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | -5091911.85 | -57.01% |
| 2024 | -11844485.47 | -147.68% |
| 2023 | 24.84M | -445.15% |
| 2022 | -7197385.60 | -681.34% |
| 2021 | 1.24M | -107.97% |
| 2020 | -15533525.00 | -316.30% |
| 2019 | 7.18M | -182.90% |
| 2018 | -8662458.00 | -193.94% |
| 2017 | 9.22M | -253.06% |
| 2016 | -6024752.00 | -365.47% |
The current Enterprise Value of Cellectar Biosciences, Inc. (CLRB) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
2.64M
5-year avg
389.19K
10-year avg
-1187213.84
Cellectar Biosciences, Inc.’s Enterprise Value is less than AEON Biopharma, Inc. (5.03M), less than Bolt Biotherapeutics, Inc. (19.46M), less than Cingulate Inc. (8.89M), greater than Sensei Biotherapeutics, Inc. (-133840780.00), less than Lyra Therapeutics, Inc. (15.15M), less than Imunon, Inc. (1.21M), greater than Marker Therapeutics, Inc. (-14642.00), greater than Evogene Ltd. (-1576119.83), greater than TransCode Therapeutics, Inc. (-7770350.00), greater than Mustang Bio, Inc. (-10652920.00),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 5.03M | $8.64M | |
| 19.46M | $8.76M | |
| 8.89M | $27.36M | |
| -133840780.00 | $17.45M | |
| 15.15M | $781.13K | |
| 1.21M | $5.09M | |
| -14642.00 | $14.90M | |
| -1576119.83 | $5.03M | |
| -7770350.00 | $5.07M | |
| -10652920.00 | $5.61M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cellectar Biosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Cellectar Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Cellectar Biosciences, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Cellectar Biosciences, Inc. (CLRB)?
What is the 3-year average Enterprise Value for Cellectar Biosciences, Inc. (CLRB)?
What is the 5-year average Enterprise Value for Cellectar Biosciences, Inc. (CLRB)?
How does the current Enterprise Value for Cellectar Biosciences, Inc. (CLRB) compare to its historical average?